An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis

Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

NCT07177209 ·Status: ACTIVE_NOT_RECRUITING

PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis

NCT03415711 ·Status: TERMINATED ·Phase: NA

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

NCT04613518 ·Status: COMPLETED ·Phase: PHASE2

A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

NCT00787202 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

NCT01470612 ·Status: COMPLETED ·Phase: PHASE3

An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis

NCT03237260 ·Status: WITHDRAWN ·Phase: PHASE4

Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis

NCT00748410 ·Status: TERMINATED ·Phase: PHASE2

Xeljanz Special Investigation for Long-term Use in UC Patients

NCT03643211 ·Status: COMPLETED

Research Study in Patients With Severe Ulcerative Colitis

NCT00032305 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

NCT04857112 ·Status: COMPLETED ·Phase: PHASE2

GSK2982772 Study in Subjects With Ulcerative Colitis

NCT02903966 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

NCT01336465 ·Status: COMPLETED ·Phase: PHASE2

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

NCT00269438 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis

NCT03934216 ·Status: COMPLETED ·Phase: PHASE2

the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative Colitis

NCT06856031 ·Status: COMPLETED

A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

NCT04700449 ·Status: COMPLETED ·Phase: PHASE2

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

NCT03648541 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

NCT02289417 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

NCT03893565 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

NCT03368118 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis

NCT00038922 ·Status: TERMINATED ·Phase: PHASE1

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ·Status: TERMINATED ·Phase: PHASE1

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

NCT05817942 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

NCT03558152 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

NCT06095596 ·Status: RECRUITING ·Phase: NA